Amneal Pharmaceuticals (AMRX) EBITDA Margin Growth (3y) (2020 - 2026)
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) EBITDA Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 1,129.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -925.00 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -2,128.00 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 293.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 693.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -230,408.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 457.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -372.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 15,005.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 293.00 |
| Mar 31, 2026 | 1,344.00 |
| Dec 31, 2025 | 785.00 |
| Sep 30, 2025 | 84.00 |
| Jun 30, 2025 | 5,088.00 |
| Mar 31, 2025 | 975.00 |
| Dec 31, 2024 | 829.00 |
| Sep 30, 2024 | 725.00 |
| Jun 30, 2024 | 106.00 |
| Mar 31, 2024 | -1,094.00 |
| Dec 31, 2023 | -166.00 |
| Sep 30, 2023 | 1,173.00 |
| Jun 30, 2023 | 1,105.00 |
| Mar 31, 2023 | -541.00 |
| Dec 31, 2022 | 1,173.00 |
| Sep 30, 2022 | 3,781.00 |
| Jun 30, 2022 | -3,083.00 |
| Mar 31, 2022 | 2,583.00 |
| Dec 31, 2021 | -260.00 |
| Sep 30, 2021 | -1,025.00 |